Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic

Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic

Objective: We aimed to use SARS-CoV-2 antibody tests to assess the asymptomatic seroprevalence of individuals in high-risk hospital cohorts who's previous COVID-19 exposure is unknown; staff, and patients requiring haemodialysis or chemotherapy after the first wave.Methods: In a single Center,...

Full description

Bibliographic Details
Main Authors: Brendan O'Kelly, Ronan McLaughlin, Roseann O'Doherty, Hailey Carroll, Roisin Murray, Rachel Dilworth, Laura Corkery, Aoife G. Cotter, Tara McGinty, Eavan G. Muldoon, Walter Cullen, Gordana Avramovic, Gerard Sheehan, Denise Sadlier, Michaela Higgins, Peter O'Gorman, Peter Doran, Rosanna Inzitari, Sinead Holden, Yvonne O'Meara, Sean Ennis, John S. Lambert
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Medicine
Subjects:
COVID-19
SARS-CoV-2
rapid antibody test
seroprevalence SARS-CoV-2
high-risk hospital cohorts
first wave
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.642318/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.642318/full

Similar Items